Johnson & Johnson (JNJ) Share-based Compensation (2009 - 2026)

Johnson & Johnson has reported Share-based Compensation for 18 years, with the latest figure at $458.0 million in Q2 2026.

• Quarterly Share-based Compensation rose 11.71% year-over-year to $458.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.4 billion (up 14.87% YoY) and the FY2025 annual result came in at $1.4 billion, up 15.14% from the prior year.
• Share-based Compensation grew to $458.0 million in Q2 2026 per JNJ's latest filing, from $300.0 million in the prior quarter.
• Over five years, Share-based Compensation peaked at $458.0 million in Q2 2026 and troughed at $178.0 million in Q4 2023.
• A 5-year average of $309.1 million and a median of $301.0 million in 2024 frame the typical range for Share-based Compensation.
• The sharpest annual moves came in 2023 and 2024: Share-based Compensation declined 18.35% in 2023, then jumped 33.71% in 2024.
• Over 5 years, Share-based Compensation stood at $278.0 million in 2022, then slumped by 35.97% to $178.0 million in 2023, then soared by 33.71% to $238.0 million in 2024, then gained by 29.83% to $309.0 million in 2025, then surged by 48.22% to $458.0 million in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $458.0 million, $300.0 million, and $309.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.